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Abstract. We report the identification of a putative 
v-SNARE (GOS-28), localized primarily to transport 
vesicles at the terminal rims of Golgi stacks. In vitro, 
GOS-28, a Golgi SNARE of 28 kD, is efficiently pack- 
aged into Golgi-derived vesicles, which are most likely 
COPI coated. Antibodies directed against GOS-28 
block its ability to bind a-SNAP, partially inhibit trans- 
port from the cis to the medial cisternae, and do not in- 
hibit budding of COP-coated vesicles, but do accumu- 
late docked uncoated vesicles. 
T 
RANSPORT vesicles shuttling cargo between intracel- 
lular organelles dock to their correct destination by 
the selective recognition of an address signal on ves- 
icles by a receptor on the intended target membrane. Ac- 
cording to the SNARE 1 hypothesis, this process is medi- 
ated  at  least  in  part  by  the  unique  pairing  of  SNAP 
receptors  localized  on  vesicles  (v-SNAREs)  with  their 
cognate t-SNARE on the target membrane (Srllner et al., 
1993a).  For example, in yeast, distinct compartment-spe- 
cific SNARE complexes acting at the ER-Golgi (S,gaard 
et al., 1994) and at the Golgi-plasma membrane transport 
steps  (Aalto et al.,  1992, 1993; Protopopov et al.,  1993) 
have been demonstrated and a  t-SNARE at the vacuole 
has been postulated (Bennett et al., 1993). In mammalian 
cells, SNARE complexes involved in regulated exocytosis 
have  been  isolated  (Srllner  et  al.,  1993a,b).  The  only 
known t-SNARE acting early in the secretory pathway is 
syntaxin 5 (Bennett et al., 1993) and its yeast homologue, 
Sed5 (Hardwick and Pelham, 1992), which have been lo- 
calized to the cis-Golgi network (Banfield et al., 1994). In 
both eukaryotes, the SNARE pattern within the Golgi ap- 
paratus is largely unknown. 
In contrast to SNARE proteins, which have to be com- 
partment specific to fulfill their proposed function, the ma- 
chinery acting in the consumption of docked vesicles, in 
the fusion process, is a general one used at multiple trans- 
port  steps.  Indeed, general fusion proteins  such  as  the 
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N-ethylmaleimide-sensitive fusion protein  (NSF)  (Block 
et al., 1988) and soluble NSF attachment proteins (SNAPs) 
(Clary and Rothman 1990; Clary et al., 1990) can be both 
found free in the cytoplasm and associated with the mem- 
branes of different organelles. The membrane interaction 
of NSF is mediated by the binding of SNAPs to SNAREs 
(Weidmann et al.,  1989; Wilson et al.,  1992). The assem- 
bled v-SNARE/t-SNARE complex provides high affinity 
sites  for  the  binding  of several  SNAPs  (Srllner  et  al., 
1993b; Hayashi et al., 1995; Schiavo et al., 1995). A  com- 
plex of SNAREs, SNAPs, and NSF can be isolated in vitro 
in the absence of hydrolyzable ATP, and migrates with 20 
Svedberg (20S particle) in velocity centrifugation (Wilson 
et al., 1992). In the presence of ATP, the ATPase activity 
of NSF provides energy to dissociate the SNARE complex 
and to release SNAPs and NSF, thereby likely linking the 
process of vesicle docking to the initiation of vesicle fusion 
(Srllner et al., 1993b). 
The secretory pathway is the major route for the deliv- 
ery of newly synthesized molecules to their intracellular or 
extracellular destinations. This requires the maintenance 
of the  compartments  comprising  the  pathway  (i.e.,  the 
constancy of their protein and lipid composition), despite 
a continuous flow of material passing through them. This 
appears to be accomplished by constant sorting events ei- 
ther excluding or enriching certain molecules in transport 
vesicles (Griffiths and Simons, 1986; Pelham and Munro, 
1993). Transport vesicles enriched in certain cargo could 
either move in an anterograde or retrograde direction, ei- 
ther selecting molecules for their forward transport to a 
distinct organelle or retrieving escaped molecules back- 
wards to their organelle of origin (Pelham, 1991). In addi- 
tion to these sorting events, import into and export from a 
distinct compartment have to be balanced to maintain its 
size and volume. This implies that the transport contain- 
ers, the vesicles, and the transport machinery have to be 
recycled, v-SNAREs that determine the address of a trans- 
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play  a  major  role  in  these  processes.  For  example,  a 
v-SNARE that has guided a vesicle to its destination be- 
comes part of the  target membrane after fusion has oc- 
curred. Most likely, this v-SNARE has to be cycled back 
to its compartment of origin, and it would seem only natu- 
ral that the number of v-SNAREs available for forward 
transport is dependent on their recycling from their target 
membrane. This would couple and balance the vesicle flow 
between two compartments. To test such predictions, it is 
necessary  to  identify  v-SNAREs  and  their  interacting 
t-SNAREs in the central turntable for vesicular traffick- 
ing, the Golgi apparatus, and its cis- and trans-Golgi net- 
works. 
On one hand, the Golgi receives both anterograde trans- 
port vesicles from the  ER  and  retrograde  vesicles from 
downstream compartments; on the other hand, it produces 
retrograde  vesicles moving back to the  ER  and  antero- 
grade vesicles moving toward the plasma membrane (Pel- 
ham, 1991;  Miesenb6ck and Rothman,  1995).  Therefore, 
the  isolation  and  characterization  of SNAREs  from the 
Golgi will be essential for our understanding of how a cell 
maintains the integrity of its organelles by integrating ve- 
sicular  flow patterns  in  a  coordinated  manner.  Further- 
more, the localization of SNAREs within the Golgi stack 
might provide us with information about the organization 
of the Golgi. For example, analysis of the distribution of 
SNAREs within a cisterna may help to define areas involved 
in vesicle budding and fusion. 
In this paper, we describe the isolation of Golgi SNAREs 
and the identification, localization, and functional charac- 
terization of GOS-28, a v-SNARE, which can act in intra- 
Golgi transport. 
Materials and Methods 
Materials 
The following materials were isolated as described elsewhere: Golgi mem- 
branes from CHO cells (Balch et al., 1984a), bovine brain cytosol (Mal- 
hotra et al., 1989),  His6-ct-SNAP (Whiteheart et al., 1993),  and recombi- 
nant His6-NSF-myc (S611ner et al., 1993b). 
Sequencing and Mass Analysis of  Peptides 
Proteins separated by SDS-PAGE were  electroblotted  onto nitrocellu- 
lose, and  the visualized bands were  processed for internal amino acid 
analysis, as described (Erdjument-Bromage et al., 1994).  Briefly, mem- 
brane-bound proteins were digested in situ with trypsin and the resulting 
peptides separated by narrowbore reverse-phase HPLC; the modular liq- 
uid chromatography system used in this study has been described else- 
where  (Elicone  et al.,  1994).  Selected  peptides were then subjected to 
chemical microsequencing and matrix-assisted laser desorption (MALDI) 
mass spectrometry, also described previously (S611ner et al., 1993a; Erdju- 
ment-Bromage et al., 1994; Tempst et al., 1994). 
Isolation of GOS-28 cDNA 
To isolate a cDNA encoding Golgi-SNARE of 28 kD (GOS-28), a two- 
stage PCR was performed with degenerate primers based on peptide se- 
quence data obtained as described (S611ner et al., 1993a). For the first 
stage of PCR, the following primers were used: ATGTT(TC)GA(AG)- 
AC(AGTC)ATGGC (codons Met66-Ala  71, sense, 0.5 p,M), TG(AG)AA- 
(TC)TC(AG)TG(AGTC)GT(AG)TA  (codons  TyrllS-His  123, antisense, 
0.5 ~M) and a bovine liver cDNA (0.5 ng, Clontech) as template. The am- 
plification reactions were performed for five cycles using an annealing 
temperature of 42°C (1 min at 94°C, 1 min at 42°C, and 2 min at 72°C) fol- 
lowed by an additional 30 cycles at an annealing temperature of 55°C 
(1 min at 94°C,  1 min at 55°C, and 2 min at 72°C). The last cycle was fol- 
lowed by an 8-min extension at 72°C. For the second stage, the PCR prod- 
ucts from the first stage were  diluted  1:1,000,  and the same antisense 
primer  as  in  stage  1  and  the  ATGGC(AGTC)AT(ATC)GA(AG)AT 
(ATC)GA (codons Met7°-Glu  75, sense) primer were added. The amplifica- 
tion conditions were the same as in stage 1. The products were fraction- 
ated by electrophoresis in 2% agarose gels. A major amplification product 
of ~180 bp was isolated, random labeled, and used as a probe for screen- 
ing a  CHO  cDNA  library  constructed with  the  Uni-ZAP XR  vector 
(Stratagene, La Jolla, CA). Hybridization was done at 50°C for 14 h in 5 x 
SSPE (1 × SSPE = 0.18 M NaC1, i mM EDTA, 10 mM NaH2PO4, pH 7.7), 
5×  Denhardt's solution, 0.5% SDS, in the presence of 20  Ixg/ml herring 
sperm DNA. The filters were washed twice in 2x SSPE, 0.1% SDS for 10 
min at room temperature, followed by a 15-min wash at 50°C in 1× SSPE, 
0.1% SDS. Positive clones were excised from the Uni-ZAP XR vector as 
inserts in pBluescript SK- by coinfection with the helper phage, ExAssist, 
as described by the manufacturer (Stratagene), and were sequenced for 
both sense and antisense strands. 
Preparation of  Antibodies 
To generate a polyclonal antibody to GOS-28, a fusion protein of GOS-28 
with an amino-terminal extension containing six histidine residues (His  6- 
GOS-28) was prepared by insertion of the GOS-28 cDNA into a pQE11 
vector (Qiagen, Chatsworth, CA).  After expression in  Escherichia  coli 
(XL1-Blue; Stratagene), the protein was purified from inclusion bodies 
under denaturing conditions by affinity chromatography using Ni-nitrilo-tri- 
acetic acid agarose as described by the manufacturer (Qiagen). His6-GOS- 
28 was eluted in 8 M urea, 0.1 M NaH2PO4, and 0.01 M Tris (pH 4.5), and 
then injected into rabbits for immunization. Antibodies directed against 
GOS-28 were purified as described (Harlow and Lane, 1988),  by affinity 
chromatography using His6--CJOS-28  conjugated to cyanogen bromide- 
activated Sepharose 4B (Pharmacia Fine Chemicals, Piscataway, N J), and 
the elutate was dialyzed against PBS. Minor contaminations of antibodies 
cross-reacting with cellular antigens other than GOS-28 were affinity de- 
pleted. For this purpose, 500 Ixg of CHO protein was separated by SDS- 
PAGE, transferred onto nitrocellulose membrane, the region containing 
proteins with a 28-kD tool mass was cut out, and the remaining nitrocellu- 
lose membrane was incubated with the affinity-purified anti-GOS-28 anti- 
bodies in 0.1% BSA. 
Fab fragments were prepared by incubating the affinity-purified anti- 
GOS-28 antibody with papain (Boehringer Mannheim Biochemicals, Indi- 
anapolis, IN), and any remaining intact antibodies and Fc fragments were 
removed by protein A-agarose chromatography (Mage, 1981).  The Fab 
fragments were dialyzed against 10 mM MOPS-KOH (pH 7.5) and 150 
mM KCI. 
Western Blot Analysis 
For  Western blot  analysis, proteins were  fractionated  by  SDS-PAGE 
(Laemmli,  1970)  and  transferred  onto  nitrocellulose  filters  or  polyvi- 
nylidenefluoride filters. Polyvinylidenefluoride membranes were used for 
the  detection  of the  p24  antigen  (Stamnes et  al.,  1995).  Filters  were 
blocked with 5% milk powder in TBS-Tween (0.1% Tween-20), and were 
incubated  with  primary  antibodies  as  indicated  (affinity-purified anti- 
GOS-28 antibody diluted 1:1,000,  anti-p24 antiserum diluted 1:1,000,  or 
anti-g-COP polyclonal antibody (Kuge et al., 1993)  diluted 1:1,000).  Im- 
munoreactive bands were visualized with HRP-conjugated secondary an- 
tibody  and  chemiluminescence (ECL  kit;  Amersham Corp.,  Arlington 
Heights, IL). 
Expression of  Epitope-tagged GOS-28 in CHO Cells 
To  obtain  CHO  cells that  stably express GOS-28  tagged with  a  myc 
epitope (EQKLISEEDL),  the coding sequence for the myc epitope was 
added by PCR to the 5' end of the coding region of the GOS-28 cDNA, 
and the resulting construct was subcloned into the mammalian cell expres- 
sion vector pcDNA3 (InVitrogen, San Diego, CA). The FLAG epitope 
(DYKDDDDK) was inserted after the initiation codon into the GOS-28 
cDNA by loop-in mutagenesis using the unique site elimination method 
(Deng and Nickoloff, 1992) and the Transformer site-directed mutagene- 
sis kit  (Clontech  Laboratories,  Palo  Alto,  CA).  CHO  cells  grown  in 
MEM-ct medium containing 10% FCS were transfected with the above- 
mentioned constructs using the  Lipofectamine  reagent  (GIBCO-BRL, 
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transfection, the cells were selected by the incubation with 1 mg/ml G418 
sulfate (GIBCO-BRL). After 7 d, several resistant colonies were isolated 
by trypsinization in cloning cups, grown in a medium containing 0.5 mg/ml 
G418,  and examined for myc-GOS-28 or FLAG--GOS-28 expression by 
Western blot analysis. 
Immunolocalization 
For immunofiuorescence, CHO cells expressing FLAG- and myc-tagged 
GOS-28 fusion proteins were fixed with 4% paraformaldehyde, and were 
permeabilized by dehydration and rehydration with ethanol. Cells were 
subsequently exposed for 2  h  at  room temperature to affinity-purified 
anti-GOS-28 antibodies (1:5) followed by a 1-h exposure to goat anti-rabbit 
IgG coupled to FITC. Anti-FLAG (M2) (Brizzard et al., 1994)  or anti- 
myc (9El0)  (Evan et  al.,  1985)  mAb revealed by FlTC-coupled anti- 
mouse IgG were used to localize FLAG- or myc-tagged GOS-28 in the 
transfected CHO cell lines. Cells were counterstained with 0.03% Evans 
blue and examined with a confocal fluorescence microscope. For electron 
microscope immunolocalization, cells were fixed with 2% glutaraldehyde 
in phosphate buffer (pH 7.4), infiltrated with 2.3 M sucrose, and processed 
for cryoultramicrotomy according to  the method of Tokuyasu  (1986). 
Anti-GOS-28 affinity-purified antibodies (diluted 1:3) were localized with 
the protein A-gold method (Roth et al., 1978) or by goat anti-rabbit IgG- 
coupled gold. Anti-myc (9E10)  antibodies (diluted 1:100 or 1:300) were 
localized with rabbit anti-mouse IgG followed by protein A-gold. After 
immunolabeling, sections were  absorption stained with uranyl  acetate 
(Tokuyasu, 1986) and examined in the electron microscope. 
Cis- to Medial-Golgi Transport  Assay 
The assay measures transport from a donor Golgi, prepared from vesicu- 
lar stomatitis virus (VSV)-infected 15B CHO cells (a mutant cell line that 
lacks UDP-[3H]-N-acetylglucosamine (UDP-GlcNAc) glycosyltransferase 
I) to an acceptor Golgi, prepared from uninfected wild-type ceils, by in- 
corporation of UDP-[3H]GlcNAc into the VSV G protein. The prepara- 
tion of assay components and standard incubation conditions were as de- 
scribed previously (Balch et al., 1984a,b;  Malhotra et al.,  1989).  Briefly, 
transport reactions contain bovine brain cytosol (5 Ixl), donor Golgi (5 Ixl), 
acceptor Golgi (5 I~1), and 0.4 ixM UDP-[3H]GIcNAc in transport buffer 
(25 mM Hepes/KOH [pH 7.0], 20 mM KCI, 2.5 mM Mg(OAc)2, 5 mM cre- 
atine phosphate, 250 }~M UTP, 50 }xM ATP, 8 IU/ml creatine kinase) in a 
final volume of 50 i~1. Transport occurs during an incubation at 37°C for i h; 
then the membranes are lysed by detergent and the VSV G protein is im- 
munoprecipitated. 
Generation of Golgi-derived Coated Vesicles 
Vesicle budding reactions contained CHO Golgi membranes (50  I~g/ml), 
bovine brain cytosol (2.4 mg/ml), 10 IxM palmitoyl Coenzyme A, 25 p.g/ml 
RNase A, and 20 ~M GTP~/S, in transport buffer. Control reactions were 
performed in the absence of GTP~/S. Reaction mixtures were assembled 
on ice and then incubated at 37°C for 15 rain. After the incubation, the 
Golgi membranes were isolated by centrifugation for 20 min at 15,800 g. 
The Golgi membrane pellet was resuspended in 0.6 ml low salt stripping 
buffer (25 mM Hepes [pH 7.2], 2.5 mM Mg(OAc)2, 0.2 M sucrose, and 50 
mM KC1), reisolated by centrifugation, and subsequently washed with 0.6 
ml high salt stripping buffer (25 mM Hepes [pH 7.2], 25 mM Mg(OAc)2, 
0.2 M sucrose, 250 mM KC1). After centrifugation, the high salt superna- 
tant was adjusted to 52% (wt/wt) sucrose. The high salt supernatant con- 
taining the coated vesicles was overlayered with 0.5 ml of 45%  sucrose 
and 1 ml of (each) 40, 35, and 30% sucrose, and centrifuged for 15 h at 
287,000 g. 350-1~1 fractions were collected from the gradient, diluted with 1 
vol H20 , and centrifuged at 356,000 g for 30 min to pellet the vesicles. The 
isolated vesicles were resuspended in Laemmli buffer for Western blot 
analysis. 
Assembly of  20S Particles on 
Immobilized GST-a-SNAP 
A  glutathione S-transferase (GST)  fusion protein of a-SNAP was pre- 
pared by inserting the a-SNAP eDNA into the pGEX-2T vector (Pharma- 
cia). The GST a-SNAP fusion protein was expressed in E. coli and puri- 
fied from the bacterial lysate on glutathione-agarose (Sigma Chemical 
Co.).  CHO  Golgi membranes were stripped of peripherally associated 
proteins by incubating with 1 M KCI for 15 min on ice, and then recovered 
by centrifugation (15,800 g, 15 min, 4°C). The membrane pellet was resus- 
pended in lysis buffer (20 mM Hepes-KOH [pH 7.2], 100 mM KCI, 1 mM 
DT1  ~, 0,5% Triton X-100, 1% glycerol) and solubilized for 45 min at 4°C 
with gentle mixing, followed by centrifugation for 45 rain at 100,000 g to 
remove detergent-insoluble material. The Golgi Triton X-100 extract (25 
p~g of protein) was incubated with the indicated amounts of affinity-puri- 
fied anti--GOS-28 antibody for 1 h  at 4°C.  Subsequently, the mixtures 
were incubated with GST-a-SNAP (1  p,g of protein) prebound to glu- 
tathione-agarose beads (15  p~l) without or with His6-NSF-myc (5  ~g of 
protein), in the presence of 0.5 mM ATP and either 2 mM EDTA or 2 mM 
MgC12, for 1 h at 4°C in a final volume of I  ml. Beads were then washed 
four times with 1 ml of the appropriate buffer, and proteins were eluted 
from the beads by incubation with 15 p~l 2× Laemmli buffer and then sub- 
jected to Western blot analysis. 
Electron Microscopy to Examine the Effect of the 
Anti-GOS-28 Antibody on Vesicular Transport 
Reactions (500 Ixl) contained 10 p.M palmitoyl Coenzyme A, bovine brain 
cytosol (2.4 mg/ml), and CHO Golgi membranes (100 p,g/ml) in transport 
buffer. For the preparation of N-ethylmaleimide (NEM)-treated Golgi, 
CHO Golgi membranes were treated with 1 mM NEM for 15 min on ice, 
followed by an addition of 2 mM DTT and an incubation for 15 rain on 
ice. Reactions were assembled on ice, preincubated on ice for 15 rain with 5 
p,g of affinity-purified anti-GOS-28 antibody and 20 ixM GTP~/S (see Ta- 
ble I), and then incubated at 37°C for 15 rain. The reactions were then 
treated with 1% glutaraldehyde, the membranes were isolated by centrifu- 
gation (15,800 g, 30 min, 4°C) and processed for electron microscopy, and 
the quantitative  evaluation of vesicles and buds was performed as de- 
scribed previously (Orci et al., 1991). 
Results 
Isolation of SNAREs  from a 
Golgi-enriched Preparation 
To gain insight into the SNARE composition of the Golgi, 
we made use of the mammalian Golgi apparatus, which is 
morphologically well defined by the existence of several 
stacked cisternae. Therefore, a preparation enriched in Golgi 
was isolated from bovine liver (Tabas and Kornfeld, 1979). 
The membranes were extracted at pH 11.5 (Fujiki et al., 
1982) to remove peripheral associated proteins and lysed 
by addition of Triton X-100. From this extract, potential 
SNARE proteins were isolated by their ability to assemble 
together with SNAPs and NSF in a 20S particle in the ab- 
sence of hydrolysable ATP. The whole particle was immo- 
bilized on beads containing covalently coupled anti-myc 
antibodies that bind the myc epitope-tagged NSF in the 
20S particle. In a control reaction, the beads were treated 
with Mg-ATP~S to release proteins that were bound in an 
Mg  2+ sensitive, ATP hydrolysis-independent manner (Fig. 1, 
lane 2). SNAPs and SNAREs were then eluted from the 
matrix by Mg-ATP treatment (S611ner et al., 1993a). In ad- 
dition to several proteins in the molecular mass range of 
70 kD, which are also visible in the control reaction, or-SNAP 
and  six  additional  protein  bands  representing potential 
SNAREs were specifically eluted as shown in the Ponceau 
S-stained Western blot in Fig. 1, lane 1. These six proteins 
migrate with an apparent molecular mass of 45 (A), 31 (B), 
26 (C), 24 (D), 21  (E), and 20 kD  (F) in high-Tris urea 
SDS-PAGE.  Microsequencing  and  mass  spectrometric 
data obtained from several tryptic peptides derived from 
these six proteins were used to search protein sequence re- 
positories and indicated that all bands corresponded to as 
yet unidentified proteins (data not shown). Further analy- 
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quence predicted from the cDNA sequence is shown.  The pep- 
tide sequences determined by microsequencing are underlined. 
The carboxy-terminal hydrophobic domain is boxed. The heptad 
repeat  showing the  potential  to form coiled  coil  structures  is 
marked by dots. The sequence data are available  from EMBL/ 
GenBank/DDBJ under the accession number U49841. 
Figure 1.  Purification  of SNAREs from  Golgi-enriched  mem- 
branes.  SNARES were purified as described (S6Uner et al., 1993a). 
Briefly, I--Iis6-NSF-myc  (500 ~g of protein) and t-Iis6--a-SNAP (500 
0~g of protein) were assembled into 20S particles by incubating 
them together with Triton X-100 extracts of enriched Golgi mem- 
branes (250 mg of protein) from bovine liver in the presence of 
ATP~/S. The 20S particles were then isolated with anti-myc mAbs 
covalently coupled to protein G-Sepharose beads (2.5 ml of 2 mg 
9El0 IgGs/mg protein G--Sepharose).  The beads were washed, 
eluted with Mg-ATP3,S, free Mg  2÷ was complexed by addition of 
EDTA, the ATP~/S was exchanged against ATP, and then the 
bound 20S particles were disassembled by a specific elution step 
with Mg-ATP. Shown is a Ponceau S-stained Western blot of the 
specific  (Mg-ATP) eluate  and the control eluate  (Mg-ATP3,S). 
The following tryptic peptide sequences (one-letter code) of the 
protein band D  were obtained by microsequencing as described 
under Materials  and Methods: (1) YL(V/E)(N/Q)EL(D/Q)([X/Y], 
both residues  observed during this cycle); (2) MFETMAIEIEQL- 
LAR; (3) MAEYTNSAGVPSLNAALMHTL; (4) HRDILQDY- 
TEEFFK; (5) ERENLMGS; (6) RTELFLKEHDHLR. Two addi- 
tional peptide sequences obtained from protein band D  showed 
an identical match with a-SNAP, and they most likely represent 
contaminations from the dominant a-SNAP band. 
sis, including the isolation of the encoding cDNA, the topo- 
logical characterization,  the intracellular  localization, and 
functional  studies,  was  performed  with  GOS-28  (repre- 
sented by protein band D  in Fig. 1). 
GOS-28 Is a Type H Membrane Protein with the Bulk of 
Its Mass Exposed to the Cytoplasm 
A  full-length clone encoding GOS-28 was isolated from a 
CHO  cDNA library,  and  the  predicted  molecular  mass 
(28.5  kD)  of the  protein  encoded  by  the  open  reading 
frame was in close agreement with the apparent molecular 
size of 24 kD (Fig. 1, protein band D). GOS-28 migrates in 
a standard Laemmli SDS-PAGE with an apparent molec- 
ular mass of 31 kD (data not shown). All six peptide  se- 
quences obtained by microsequencing of the protein hand D 
aligned perfectly with the translation product of the open 
reading frame (Fig. 2). GOS-28 has no obvious signal pep- 
tide, and contains a region (amino acids 63-95) with an in- 
herently  high  probability  to  form  coiled  coil  structures. 
The  amino  terminal  region  could  also  form  coiled  coil 
structures,  but with lower probability.  GOS-28 is further 
characterized  by a  carboxy-terminal  hydrophobic region 
Figure 3.  GOS-28 is a cytoplas- 
micaUy oriented  integral  mem- 
brane protein.  (A) Anti--GOS-28 
antibodies specifically  recognize 
GOS-28  in  total  cell  extracts. 
CHO  cells  stably  transfected 
with the FLAG epitope-tagged 
GOS-28 were lysed in Laemmli 
buffer,  and  the  proteins  were 
separated by SDS-PAGE, trans- 
ferred  on  nitrocellulose,  and 
immunodecorated with affinity- 
purified anti-GOS-28 antibodies 
as  described  in  Materials  and 
Methods. The upper band repre- 
sents the FLAG epitope-tagged 
GOS-28; the lower band repre- 
sents the endogenous GOS-28. These stably transfected cells were also used for the immunolocalization studies.  (B) GOS-28 is an inte- 
gral membrane protein. CHO Golgi membranes were incubated either with 1 M NaC1 or 200 mM Na2CO3 (pH 11.3) for 30 min on ice. 
The membranes were isolated by centrifugation at 356,000 g for 45 rain. The supernatants were precipitated by TCA, and the pellets 
were analyzed by immunodecoration of Western blots with anti-GOS-28 antibodies, as described in Materials and Methods. (C) The 
bulk of GOS-28 is exposed to the cytoplasm. CHO Golgi membranes were treated with indicated concentrations of proteinase K (Boeh- 
ringer Mannheim) at 16°C  for 30 min in 20 mM Hepes-KOH (pH 7.2), 25 mM KC1, and 200 mM sucrose. Reactions were stopped by the 
addition of 10 mM PMSF. Samples were precipitated by TCA and analyzed for GOS-28 and p24 as described in B. 
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Clusters of CHO cells viewed by confocal microscopy after im- 
munofluorescent  staining with affinity-purified anti-GOS-28 an- 
tibodies (A), FLAG mAb (B), or myc mAb 9E10 (C). In all three 
conditions, a distinct spotty juxtanuclear fluorescence is visible. 
×490. Bar, 10 ~m. 
presumably acting as a membrane anchor (see Fig. 2). Stud- 
ies using a polyclonal antibody (Fig. 3 A) raised against re- 
combinant GOS-28, which was expressed in and purified 
from E. coli, revealed that GOS-28 resists salt and sodium 
carbonate extraction of the Golgi (see Fig. 3 B). Both cri- 
teria are consistent with the properties expected for an in- 
tegral membrane protein. The bulk of the protein seems to 
be exposed to the cytoplasm since GOS-28 was degraded 
by addition of low amounts of protease to isolated Golgi 
(see Fig. 3  C). A  control protein, p24, an integral mem- 
brane protein, the bulk of whose mass is localized in the 
Golgi lumen was protease resistant (Stamnes et al., 1995). 
Protease treatment of detergent-solubilized Golgi showed 
that  p24  is  not  inherently  protease  resistant  (data  not 
shown). These data, together with the existence of a single 
membrane-spanning  region  at  the  carboxy terminus  of 
GOS-28, argue for a type II membrane protein. These re- 
sults  also confirm the identity of the isolated clone and 
GOS-28 obtained by its association with SNAPs and NSF. 
GOS-28 Is Localized to the Golgi Region 
Since the starting material used for the SNARE isolation 
was enriched for Golgi membranes, one would predict that 
the majority of the recovered SNAREs  should be local- 
ized within the Golgi or representing SNAREs that medi- 
ate the docking of anterograde or retrograde vesicles to 
the  Golgi. Immunofluorescence localization experiments 
were performed to confirm this  for GOS-28.  Polyclonal 
antibodies  raised  against  GOS-28  and  mAbs  directed 
against  the  FLAG  and  myc epitope  of amino  terminal 
FLAG-GOS-28 and myc-GOS-28 fusion proteins stably 
expressed in CHO cells were used for these studies (see 
Fig. 4). In all three cases, GOS-28 exhibits a clear juxtanu- 
clear staining pattern that is characteristic of Golgi pro- 
teins. 
Electron microscope immunocytochemistry revealed that 
GOS-28 is primarily localized to vesicles and buds at the 
ends of the cisternae, with little labeling of the cisternae 
themselves both in situ and in cell-free assays (Figs. 5 and 
6 A-C). The very low levels of labeling of the central re- 
gions  of  stacked  cisternae  precluded  an  assignment  of 
GOS-28 to  c/s versus medial versus  trans regions. Since 
this distribution of GOS-28 could be indicative of a func- 
tional specialization of the terminal rim of cisternae for 
vesicle budding and fusion, Golgi complexes were primed 
in vitro to accumulate coated buds and vesicles, and were 
further analyzed by electron microscopy (Fig. 6, B and C). 
A  few labeled  vesicles were  observed in  relationship 
with the c/s-Golgi pole, and occasionally buds on the tran- 
sitional elements of the ER were also found labeled (data 
not shown). A comparable distribution of immunolabeling 
was observed in insulin ceils of the rat pancreas (not shown). 
GOS-28 Is Found in Coated Vesicles 
The presence of GOS-28 in Golgi-associated buds and ves- 
icles, as seen by electron microscopy, argues that GOS-28 
is a v-SNARE. To confirm this, Golgi-derived transport ves- 
icles were accumulated in vitro by incubating purified Golgi 
in the presence of cytosol, ATP, and  a  nonhydrolyzable 
GTP analogue, GTP~/S. GTP~/S binds to the ADP-ribosyl- 
ation factor (ARF), thus keeping it in its active conforma- 
tion, which recruits coatomer to membranes (Melancon et 
al., 1987; Serafini et al., 1991; Donaldson et al., 1992). The 
coat proteins deform the membrane, thereby shaping vesi- 
cles, which finally pinch off from their donor compartment 
(Ostermann  et  al.,  1993).  Since GTP~/S is,  at  best,  only 
Nagahama et al. SNAREs  511 Figure 5.  Immunolocalization  of 
GOS-28  to the Golgi region  of 
CHO  cells.  (A-C) Thin cryosec- 
tions of the Golgi area of non- 
transfected CHO  cells labeled 
with affinity-purified  anti--GOS- 
28  antibodies, showing  a  pre- 
dominance of  labeling  of  endog- 
enous  GOS-28  on  the  vesicle/ 
bud elements situated on the lat- 
eral parts of the cisternae (A, ar- 
rows)  forming the  Golgi stack 
(G). Approximately 30% of the 
Golgi-associated  vesicles  were 
labeled.  A  comparable pattern 
of labeling of myc-tagged, over- 
expressed  GOS-28  is  obtained 
with  the  monoelonal  anti-myc 
antibody on another set of cryo- 
sections  (D and E) from stably 
transfected CHO cells. The pre- 
dominant distribution  of immu- 
nogold particles  over the lateral 
bud/vesicular  elements  of  the 
Golgi stack is particularly evident 
in E. Incubation with preimmune 
serum  did  not  elicit  labeling. 
The asterisk  in A  indicates  the 
nucleus. In A, B, D, and E, anti- 
bodies were detected with protein 
A--gold (size of particles = 10 rim); 
in  C, antibodies  were detected 
with  goat  anti-rabbit  IgG-gold 
(size  =  15 nm). A,  ×79,000; B, 
×75,000;, C, ×56,000; D, ×67,000; 
E, ×62,000. Bar, 0.1 ~m. 
slowly hydrolyzed, ARF and coatomer are locked on the 
vesicles, thereby preventing fusion and accumulating COPI- 
coated vesicles, which differ in their density from the orig- 
inating compartments. Density equilibrium centrifugation 
thus separates COPI-coated vesicles produced in this man- 
ner from parental Golgi membranes. 
Indeed, GOS-28 is shifted into the COPI-coated vesicle 
peak (marked by C-COP) only when GTP~/S is added (Fig. 7), 
implying that  GOS-28  is  a  v-SNARE because it  is  effi- 
ciently packed into vesicles. Interestingly, the distribution 
of GOS-28 only coincides with about half of the  C-COP, 
suggesting that some COPI-coated vesicles contain GOS-28 
while others do not. This is consistent with the finding that 
only 30% of vesicles label for GOS-28 (Fig. 5). 
The presence of GOS-28 in  COPI-coated vesicles was 
also shown by electron microscope immunocytochemical 
analysis of vesicles produced from isolated Golgi stacks by 
purified ARF and coatomer (Fig. 6  B),  and in  complete 
transport reactions inhibited by aluminum fluoride (Fig. 6 
C). The cisternal areas labeled with anti-GOS-28 antibod- 
ies  coincide  with  those  labeled  by anti-C-COP  antibody 
(Fig. 6 D), indicating that the terminal rims of the Golgi 
cisternae are likely to be the active zones of vesicle bud- 
ding. Although all these data strongly suggest the presence 
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buds at the terminal rims of Golgi cisternae. (A) 
Tangential  view of a CHO cell Golgi complex 
(G) in situ showing the distribution of GOS-28 
on peripherally  located  vesicular elements  (ar- 
rows) in CHO cells stably transfected with over- 
expressed FLAG-tagged GOS-28. Immunolabel- 
ing was done with affinity-purified anti-GOS-28 
antibodies. (B) Cell-free transport reactions. An 
isolated Golgi complex with cisternal and coated 
vesicular elements: only the  latter  shows a dis- 
tinct  GOS-28 immunolabeling on the outer as- 
pect  of the  vesicle membrane.  Golgi fractions 
were incubated with purified ARF and coatomer 
in presence of GTP, and were labeled with affin- 
ity-purified anti-GOS-28 antibodies. (C) Lateral 
part of an isolated Golgi complex. The GOS-28 
immunolabeling appears restricted to the cister- 
nal tips and associated vesicles. Golgi fractions 
were  incubated  in the  presence  of cytosol and 
aluminum fluoride,  as described  by Orci et al. 
(1989). Samples were labeled with affinity-puri- 
fied anti-GOS-28  antibodies.  (D) Section com- 
parable  to that  in  C, but  immunolabeled  with 
anti-I-COP antibodies. The labeling pattern  is 
essentially similar to that with anti-GOS-28 anti- 
bodies. The Golgi fractions were  incubated  in 
presence of cytosol and GTP~/S, as described by 
Orci et al. (1989). In all experiments, the protein 
A-gold labeling technique  described in Materi- 
als and Methods was used; size of gold particles 
=  10  nm.  A,  x90000; B,  x65000;  C  and  D, 
x64000. Bar, 0.1 Ixm. 
of GOS-28 in COPI-coated vesicles, we can not exclude 
that  GOS-28 might be  also found in  a  different class of 
Golgi-derived vesicles. 
Anti-GOS-28 Antibodies Inhibit Intra-Golgi  Transport 
by Blocking the Interaction of GOS-28 and a-SNAP 
Isolated Golgi membranes were incubated with increasing 
amounts of affinity-purified IgGs directed against GOS-28. 
The samples were then incubated under conditions recon- 
stituting transport. Transport was measured by glycosyla- 
tion of the cargo protein VSV G (incorporation of radiola- 
beled GIcNAc). Transport was blocked by the antibody in 
a  dose-dependent manner. The maximum inhibition was 
40-50%, and was reached by the addition of 0.5 l~g IgG to 
5 Ixg Golgi protein in a 50-1xl reaction (see Fig. 8 A). Addi- 
tion of 1 p~g purified cytoplasmic domain of GOS-28 to a 
reaction had no effect on transport,  but completely pre- 
vented  the  inhibitory  effect  of  1  p.g  anti-GOS-28  IgG 
(data not shown), thus excluding unspecific effects caused 
by the addition of IgG. In addition, control IgG prepared 
from preimmune serum had no significant effect on trans- 
port. To avoid potential aggregation of Golgi stacks or po- 
tential clustering of GOS-28 on the membranes caused by 
the bivalent IgGs, Fab fragments were prepared. The ad- 
dition of Fab fragments also resulted in a partial inhibition 
of transport, similar to that obtained with the IgG, but the 
Fab had to be added at three- to fourfold higher concen- 
trations to observe the maximal effect (see Fig. 8 B). This 
could be explained by an inactivation of the Fabs during 
their preparation procedure or by the lower avidity of Fabs. 
To establish at which particular stage the antibody blocks 
transport, the reactions were analyzed by electron micros- 
copy. Therefore, transport reactions were either incubated 
with GTP~/S, known to accumulate coated vesicles  (Melan- 
con et al., 1987), or with the anti-GOS-28 antibody to test 
for any morphological effects caused by the antibody. A 
combination of anti-GOS-28  antibody  and  GTP~/S  was 
used to test if the antibody blocks the formation of coated 
vesicles or acts at a later step. In other reactions, the mem- 
branes were treated with NEM to block the NSF activity, 
thus accumulating docked uncoated vesicles (Malhotra et 
al., 1988). The control reaction consisted of standard trans- 
port conditions. As shown in Table I, NEM caused, as ex- 
pected, a fourfold increase (relative to the control) in un- 
coated circular profiles associated with the Golgi, and did 
not result  in  accumulation of coated vesicles.  The anti- 
GOS-28 antibodies increased the number of uncoated cir- 
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F/gure  Z  GOS-28 is present in Golgi-derived  coated vesicles. 
Golgi membranes were incubated under transport conditions in 
the presence or absence of GTI~S, as described in Materials and 
Methods.  Briefly, after the GTP~/S treatment, the membranes 
were isolated and incubated with buffer containing 250 mM KCI 
to remove associated vesicles. After centrifugation, the supema- 
tant coDtainin~  the vesicles was adjusted  to 52%  sucrose  and 
overlayed with  a 30-52%  sucrose  gradient.  Gradient fractious 
were subjected  to Western blot analysis with anti-X-COP poly- 
clonal antibodies and anti--GOS-28 polydonal antibodies. 
cular profiles associated with the Golgi by 3.2-fold, similar 
to the effect of NSF inactivation. The antibody did not in- 
hibit the accumulation of coated vesicles by GTI~S, dem- 
onstrating that the anti-GOS-28 antibody inhibits trans- 
port at some stage after coated vesicle budding. Therefore, 
while the anti--GOS-28 antibody does not block the forma- 
tion of coated vesicles, it clearly blocks the comumption of 
docked uncoated vesicles before fusion can occur. 
A putative SNARE protein such as GOS-28 should bind 
SNAP, particularly when it is assembled in v-t-SNARE 
complexes. To test this, detergent extracts of Golgi mem- 
branes were incubated with an affinity matrix containing 
immobilized or-SNAP (GST--ct-SNAP fusion protein bound 
to glutathione-agarose). GOS-28 associated with a-SNAP 
(Fig. 9, lane 1), implying that GOS-28 can interact directly 
with a-SNAP or, more likely, that GOS-28 assembled in a 
v-t-SNARE complex provides high affinity sites for the 
binding of a-SNAP. This interaction is not a dead-end pro- 
cess because NSF releases the bound GOS-28 from the im- 
mobilized a-SNAP  in presence of Mg-ATP, a  hallmark 
property of SNAREs (S6Uner et al., 1993b) (Fig. 9, lane 9). 
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Figure 8.  Anti-GOS-28 antibodies  inhibit  c/s- to medial-Golgi 
transport in  vitro.  Enriched Golgi  fractions  were assayed  for 
transport of VSV G protein between c/s- and medial-Golgi com- 
partments,  as described (Balch et al., 1984a,b; see also Materials 
and Methods). The reactions (50 ixl)  were preincubated on ice for 
1 h with the indicated amounts of preimmune  IgG (A), affinity 
purilied anti--GOS-28 antibody (A), control Fab fragments pre- 
pared from preimmune IgG (B), or anti--GOS-28 Fab fragments 
(B) before incubation at 37"C for I h. 
The accumulation of docked uncoated vesicles revealed 
by electron microscopy would imply that anti-GOS-28 an- 
tibody should block fusion, but not docking. Consistent 
with this, anti--GOS-28 antibody blocked the binding of 
GOS-28 to a-SNAP in a  dose-dependent manner until a 
maximum inhibition of ~80% was reached by adding 2.5 ~g 
IgG to 25 ~g Golgi protein (see Fig. 9, lanes 2--4). Preim- 
mune antibodies had no effect on the interaction of GOS- 
28 with a-SNAP (Fig. 9, lane 5). The anti--GOS-28 IgG/ 
Golgi ratio needed to obtain maximum inhibition of the 
GOS-28hx-SNAP interaction is the same as that is needed 
for maximum inhibition of transport, implying that the in- 
Table L Anti-Gos-28 Antibodies Cause the Accumulation of  Docked Uncoated Vesicles 
Sample  Density of total circular  profiles  Density of uncoated circular  profiles  Density of coated circular  profiles 
(=a~r per V~) 
Control  8,73 -- 0.48  2.01  _+ 0.29  6.73 -- 0.37 
+GTI~S  18.75 --- 0.79  1.92 +  0.36  16.83 -+ 0.78 
+NEM  13.23 +  0.66  8.10 +  0.55  5.13 +- 0.36 
+anti--GOS-28 IsG  11.42 -+ 0.60  6.51  +  0.55  4.90 _+ 0.39 
+anti-GOS-28 IgG and GTI~S  20.76 _+ 0,83  0.95 +  0.20  19,81  -+ 0.84 
Untreated or NEM-txeated ClIO Golgi membranes were incubated under tlanstx~  conditions in the presence or absence of alTmity-purified anti-GOS-28 antibodies and GTP'yS, 
as described in Matedah and Metimds. For electron microscopy, nlemtmmes weze fixed, cullected  bY centrifugatio~a, and ProCessed as described (Orci et al-, 1991). For each of the 
samples the density of coaled vesicles/buds  and uncoated circular profiles mated  with the Golgi wexe analyzed in 20-30 separate Golgi areas in each of the three independent 
expedmen~ Numbe~ are mean values ±  SF.M. 
The Journal of Cell Biology, Volume 133, 1996  514 Figure 9.  Anti-GOS-28 antibodies  inhibit the assembly of the 
20S fusion particle.  Triton X-100 extract of CHO Golgi mem- 
branes  (25  I~g  protein)  was  preincubated  with  the  indicated 
amounts of anti-GOS-28  antibody for 1 h on ice, as described in 
Materials and Methods. Then GST--a-SNAP (1 I~g) prebound to 
glutathione  beads was added,  and the incubation  continued for 
another hour at 4°C in the absence or presence of 5 p.g His~-NSF- 
myc and either ATP/EDTA or ATP/Mg 2+ as indicated. Proteins 
bound to the beads were isolated, the samples were washed, and 
the proteins were further analyzed by SDS-PAGE, transferred to 
nitrocellulose  membranes,  and analyzed by labeling with anti- 
GOS-28 antibodies, as described in Materials and Methods. 
teraction measured in the detergent extract faithfully rep- 
resents the effects seen in the in vitro transport assay. 
Discussion 
Here, we report the isolation and characterization of a 28-kD 
Golgi membrane protein, GOS-28, fulfilling all of the cri- 
teria currently available to define a  v-SNARE.  GOS-28 
has a single membrane-spanning region at its carboxy ter- 
minus,  and  the bulk of the protein (the  amino terminal 
part)  is  exposed to the  cytoplasm and  has  the inherent 
probability to form a  coiled coil structure. Furthermore, 
GOS-28 binds directly or indirectly to a-SNAP, and ATP 
hydrolysis by NSF results in dissociation of this interac- 
tion. Morphological studies revealed that GOS-28 is local- 
ized to the Golgi apparatus with an enrichment on vesicu- 
lar components at the terminal rims of the Golgi. Electron 
microscopy analysis and  fractionation show the efficient 
inclusion of GOS-28 in COP-coated vesicles, budding in 
vitro. Antibodies directed against GOS-28 partially inhibit 
transport from c/s- to medial-Golgi, accumulating uncoated 
docked vesicles, and also inhibit the binding of GOS-28 to 
a-SNAP,  implying that the  binding  of a-SNAP  to com- 
plexes containing GOS-28is needed for fusion after docking. 
A possible discrepancy in our findings is that while anti- 
GOS-28 antibodies block transport by only 40--50%, they 
inhibit  GOS-28  binding  to  a-SNAP  by  at  least  80%. 
Among other possibilities, this difference could reflect an 
essential  difference between  the  two  assays.  The  mem- 
branes used in the transport assays contain sufficient en- 
dogenous a-SNAP  to  fulfill transport  (Clary  and  Roth- 
man,  1990),  implying that  two  populations  of SNAREs 
might exist in them: one free of endogenous a-SNAP and 
another associated with endogenous a-SNAP. The former 
would  be  inhibited  by GOS-28  antibody,  but  the  latter 
would not, resulting in the partial inhibition of transport. 
On the other hand, in the binding assay, the GST--a-SNAP 
matrix would only bind the free GOS-28 pool, which will 
also be accessible to the anti-GOS-28 antibodies. The an- 
tibody would then efficiently block the GOS-28--~-SNAP 
association, but only partially inhibit transport. 
What is the role of GOS-28 as  a  v-SNARE  in  Golgi 
transport  processes?  What  routes  within  the  stack  are 
specified by this v-SNARE? Answering these important 
questions will require identifying the cisternae of origin of 
GOS-28, as well as the location of its partnering t-SNAREs 
in (or outside of) the stack. Unfortunately, because of the 
extremely efficient packing of GOS-28 into vesicles, it has 
not been possible to pinpoint the origin of vesicles con- 
taining GOS-28 in favor of c/s versus trans cisternae, and 
the parmering t-SNAREs are still unknown. Attempts to 
test for the interaction with one potential partner, syntaxin 
5 (Sed5), have revealed binding (data not shown), but its 
specificity could not be conclusively demonstrated. 
The inhibition of reconstituted c/s-to-medial transport 
by anti--GOS-28 antibody would suggest that GOS-28 is a 
v-SNARE for this step. The need for GOS-28, however, 
could be indirect; e.g., GOS-28 could be necessary for ret- 
rograde transport from medial- to c/s-Golgi, or for both 
anterograde and retrograde steps connecting these com- 
partments.  For example,  Pelham  and  colleagues  have 
reported that a v-SNARE, Sftlp, is localized to the medial- 
Golgi in yeast (Banfield et al., 1995) and partners the c/s- 
Golgi t-SNARE Sed5p (SCgaard et al., 1994). Yet, Sftlp is 
required for c/s-to-medial transport in vivo. As proposed 
by Pelham, Sftlp could be used for retrograde transport 
from later cisternae to the c/s compartment, and the block 
in  anterograde  transport  could  be  a  secondary  conse- 
quence of the lack of recycling of critical anterograde ma- 
chinery (perhaps Sftlp itself) back to the c/s-Golgi. In vivo 
(Banfield et al., 1995), the anterograde block is complete; 
in vitro, it would be partial if multiple rounds were re- 
quired. This could be another explanation (see above) of 
why antibodies to GOS-28 partially inhibit  c/s-to-medial 
transport in vitro, reflecting the fraction of anterograde 
transport that is dependent on recycling in vitro under the 
conditions we used. 
Although the precise function of GOS-28 has not been 
completely established, GOS-28 is dearly a new member 
of the SNARE family, and the first mammalian v-SNARE 
localized to the Golgi and implicated in intra-Golgi trans- 
port. The predominant localization of GOS-28 to vesicular 
structures at the terminal rims of Golgi cisternae and its 
low abundance at the central cisternal region indicate that 
the terminal rims of Golgi cisternae are functionally spe- 
cialized sites for the entry and exit of transport vesicles. 
Further understanding  of the functional organiTation of 
the Golgi stack and its vesicular flow patterns will require 
the discovery of additional SNAREs  and possibly other 
targeting molecules, as well as understanding their interac- 
tions. 
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